Dale Starkie

Dale Starkie is a seasoned professional in the field of biotechnology with extensive experience in antibody discovery and development. Currently serving as Director at both DJS Antibodies and AbbVie since January 2022 and October 2022, respectively, Dale also held key positions at UCB from July 2012 to January 2022, including Principal Scientist - Group Leader and Senior Scientist. Dale's work at UCB involved diverse therapeutic projects and extensive collaborations with industrial partners and academic institutions. Additionally, Dale completed a PhD in Neuroscience at UCL from 2015 to 2021, where research was conducted under the supervision of Selina Wray. Prior educational background includes a degree in Virology from the University of Warwick, earned between 2008 and 2012.